Transpara implemented for clinical use by key thought leaders in radiology and breast imaging. BALTIMORE, March 12, 2024 /PRNewswire/ -- ScreenPoint Medical, announced today that its industry leading Transpara Breast AI is available to improve cancer detection for Johns Hopkins breast cancer screening patients.

Transpara由放射学和乳腺成像领域的关键思想领袖实施用于临床。巴尔的摩，2024年3月12日/PRNewswire/--ScreenPoint Medical今天宣布，其业界领先的Transpara Breast AI可用于改善约翰·霍普金斯乳腺癌筛查患者的癌症检测。

Transpara assists radiologists with the reading of 2D and 3D mammography exams, providing a 'second pair' of eyes to help detect cancers earlier and reduce recall rates. .

Transpara帮助放射科医生阅读2D和3D乳房X光检查，提供“第二对”眼睛，以帮助早期发现癌症并降低召回率。。

Continue Reading

继续阅读

Trusted by the world's most respected providers; Transpara supports half a million screenings in just 5 states and DC.

受到世界上最受尊敬的供应商的信任；Transpara仅在5个州和DC支持50万次筛查。

The Johns Hopkins Kimmel Cancer Center was one of the first to be recognized by the National Cancer Institute as a 'Center of Excellence.' Across Johns Hopkins, the breast imaging services team conducts more than 77,000 breast imaging exams and 5,000 interventional procedures each year. The choice to use Transpara was made after a thorough analysis of the software's evidence, effectiveness, and performance on selected cases.

约翰·霍普金斯·金梅尔癌症中心是首批被美国国家癌症研究所认定为“卓越中心”的中心之一在整个约翰·霍普金斯大学，乳房成像服务团队每年进行超过77000次乳房成像检查和5000次介入手术。在对选定案例的软件证据、有效性和性能进行彻底分析后，选择使用Transpara。

Transpara, trusted by key breast imaging thought leaders around the world, was evaluated in a thorough competitive comparison by the breast imaging team at Johns Hopkins..

约翰·霍普金斯大学的乳房成像团队对Transpara进行了全面的竞争性比较，对Transpara进行了评估，Transpara受到了世界各地关键乳房成像思想领袖的信任。。

The ScreenPoint customer success team worked closely with both clinical and IT teams at Johns Hopkins to install Transpara Breast AI to support patient care at 7 locations. Transpara was chosen to improve screening workflow, decision confidence, and breast cancer diagnostic assessment.

ScreenPoint客户成功团队与约翰·霍普金斯大学的临床和IT团队密切合作，在7个地点安装Transpara Breast AI以支持患者护理。选择Transpara是为了改进筛查工作流程，决策信心和乳腺癌诊断评估。

'We are delighted Johns Hopkins has trusted ScreenPoint Medical in its fight against cancer.  Transpara is the most clinically validated breast AI on the market, proven to enhance radiologists' ability to detect breast cancer as early as possible. As part of The ScreenPoint Experience, once a customer has chosen to use Transpara, we want to create those benefits within weeks, not months!  said Nicki Bryan, VP of Sales at ScreenPoint Medical.

“我们很高兴约翰·霍普金斯大学信任ScreenPoint Medical与癌症作斗争。Transpara是市场上经过临床验证最多的乳腺AI，被证明可以提高放射科医生尽早发现乳腺癌的能力。作为ScreenPoint体验的一部分，一旦客户选择使用Transpara，我们希望在几周内而不是几个月内创造这些好处！ScreenPoint Medical销售副总裁尼基·布莱恩（NickiBryan）表示。

'We are also so grateful to the professionals on the Johns Hopkins team who collaborated so effectively to ensure a smooth and seamless technical transition!'With the onboarding of Johns Hopkins, Transpara's growing utilization in the northeast will now benefit radiologists and patients in over 50 sites throughout 5 states (NY, NJ, PA, MD, VA) and the District of Columbia. Transpara is FDA cleared and has European MDR approval for use with 2D and 3D mammography from multiple manufacturers.

“我们也非常感谢约翰·霍普金斯大学团队中的专业人士，他们如此有效地合作，确保了平稳无缝的技术过渡！”随着约翰·霍普金斯大学（Johns Hopkins）的加入，Transpara在东北部的应用越来越广泛，现在将使5个州（纽约州、新泽西州、宾夕法尼亚州、马里兰州、弗吉尼亚州）和哥伦比亚特区50多个地点的放射科医生和患者受益。Transpara已获得FDA批准，并已获得多家制造商的欧洲MDR批准，可用于2D和3D乳房X光检查。

Used by hundreds of leading centers in more than 30 countries. Transpara is designed to work concurrently with radiologists. Research shows that up to 45% of interval cancers can be found earlier using Transpara, while helping to reduce workload and optimize workflow.About ScreenPoint Medical ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment.

被30多个国家的数百个领先中心使用。Transpara旨在与放射科医生同时工作。研究表明，使用Transpara可以更早地发现多达45%的间隔癌症，同时有助于减少工作量和优化工作流程。关于ScreenPoint Medical ScreenPoint Medical将尖端的机器学习研究转化为放射科医生可以使用的技术，以改进筛查工作流程，提高决策信心和乳腺癌风险评估。

Transpara is trusted by radiologists globally because it has been developed by experts in machine learning and image analysis and updated with user feedback from world-renowned breast imagers. See all the proof at: https://screenpoint-medical.com/published-evidence/peer-reviewed-publications Photo - https://mma.prnewswire.com/media/2360202/Transpara_users.jpgLogo .

Transpara受到全球放射科医生的信任，因为它是由机器学习和图像分析专家开发的，并根据世界知名乳房成像仪的用户反馈进行更新。查看以下所有证明：https://screenpoint-medical.com/published-evidence/peer-reviewed-publications照片-https://mma.prnewswire.com/media/2360202/Transpara_users.jpgLogo。